Teva Pharmaceutical Industries Ltd
Veridion Score
Composite trend over time
Why is TEVA moving today?
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for TEVA.
TEVA insider activity
Teva Pharmaceutical Industries Ltd
No multi-insider buying cluster in the last 90 days
Net selling: -$92.8M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-22 | 2026-06-18 | Shields Matthew | Insider | sell | $32.19 | 9,989 | Not reported | $322K | SEC Form 4 |
| 2026-06-16 | 2026-06-11 | Kalif Eliyahu Sharon | Insider | sell | $34.10 | 106,563 | 65,621 | $3.6M | SEC Form 4 |
| 2026-06-08 | 2026-06-05 | Francis Richard D | Insider | sell | $34.35 | 6,153 | 1,177,529 | $211K | SEC Form 4 |
| 2026-06-04 | 2026-06-03 | Shields Matthew | Insider | sell | $32.87 | 16,195 | 9,989 | $532K | SEC Form 4 |
| 2026-05-18 | 2026-05-14 | Lippman Evan | Insider | sell | $35.58 | 35,912 | 44,191 | $1.3M | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 48 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moTEVA contract awards, year to date.
Public federal awards linked to this ticker.
TEVA lobbying filings, year to date.
Registered lobbying filings matched to Teva Pharmaceutical Industries Ltd.